New radiotheranostic targets identified for diagnosis and treatment of endometrial cancer
Two molecular targets—human epidermal growth factor 2 (HER2) and cluster of differentiation 24 (CD24)—are highly promising candidates for new nuclear diagnostics and therapeutics for endometrial cancer, according to new ...
Sep 5, 2025
0
0








